Avidity Biosciences (RNA) Debt to Equity: 2019
- Avidity Biosciences' Debt to Equity was N/A to -$0.07 in Q4 2019 from the same period last year, while for Dec 2019 it was -$0.07, marking a year-over-year change of. This contributed to the annual value of -$0.07 for FY2019, which is N/A change from last year.
- According to the latest figures from Q4 2019, Avidity Biosciences' Debt to Equity is -$0.07.
- Avidity Biosciences' Debt to Equity's 5-year high stood at -$0.07 during Q4 2019, with a 5-year trough of -$0.07 in Q4 2019.
- Over the past 1 years, Avidity Biosciences' median Debt to Equity value was -$0.07 (recorded in 2019), while the average stood at -$0.07.
